Gözde Zafer, Gracemary Yap, Daniel Soo, members of Tech Observer medical writing team in Singapore put down their pen & paper, stopped typing on their keyboard and joined an overnight charity walk last weekend. 💪 The overnight charity walk, Let's Take A Walk 2023, attracted over 2,000 participants & managed to raise over SGD200,000 for charity. Tech Observer also donated SGD1,000 to the event.
About us
Good medical writers not only know how to identify the most critical data in scientific and medical research; they also able to present them in salient and reader-friendly manner. Our writers pore through pages and pages of data to hunt for the extra detail discovering what all researchers know by heart: “In ordinary data lies extraordinary answer.” Afterall, we have delivered over 200 medical writing assignments and more than 40 publications. Talk to us today to find out about our experience for clinical and regulatory writing, as well as scientific communications. Let’s make the complex simple.
- Website
-
http://www.tech-observer.com/cro/medical-writing/
External link for medicalcommunications
- Industry
- Writing and Editing
- Company size
- 51-200 employees
- Headquarters
- Paramus, New Jersey
- Founded
- 2005
- Specialties
- medical writing, scientific publications, clinical trial report, study protocol, medical affairs, and medical communications
Updates
-
A group photo with our clinical project managers & interns! 💓
Founder & Co-Owner | Having fun at Tech Observer Asia Pacific | 和Tech Observer 的同仁们在欢愉的气氛中为客户创造最大的价值！
It's not often that we have so many people in the office as Tech Observer Asia Pacific practices flexi-workplace. Our flexi-workplace policy allows our team to work in the office or remotely. 🙂 So, we took the opportunity to take a group shot when our multi-national & diverse team of clinical project managers, medical communications professionals, and our interns turned up to work in the office today! ✌️
-
-
IT’S A WRAP! Experts from the Asia Pacific Leukemia Consortium concluded their consensus meeting successfully. 💪 Next up, writers from Tech Observer will be working with the experts to develop a consensus article summarising their agreement in the treatment of Chronic Lymphocytic Leukaemia (CLL). #medicalaffairs #medicalwriting #medicalcommunications #oncology #leukemia
-
-
Tech Observer medical communications team getting ready for a consensus meeting on the treatment of Chronic Lymphocytic Leukaemia.
-
-
Recently, our Writer's Club session delved into scales in biomedical research. Organized by Gracemary Yap, Writer’s Club is part of Tech Observer’s ongoing capacity building sessions. Inspired from our lessons from recent projects involving abstract concepts such as “health” or “wellness”, the session deepened our understanding of social scientific scales and honed our skills in critical evaluation. Our team left the session with a deeper appreciation of how social, psychological, cultural dimensions enrich biomedicine. Two things to celebrate! This session was our liveliest yet, with colleagues and consultants joining virtually from all across Asia. A special shout-out to Renee Chuah, our Medical Communications intern, who gamely took on the challenge and did such a great job designing & leading the session. #capacitybuilding #biomedicalresearch #medicalcommunications
-
-
Tech Observer was tasked to work on a consensus paper for Chronic Lymphocytic Leukaemia (CLL). Our medical writing team was at Singapore General Hospital to meet Dr Yeow Tee Goh who is one of the steering committee members for this paper. Tech Observer team received tons of guidance & input from Dr Goh. Thank you, Dr Goh! We are grateful for this opportunity to work on this interesting assignment. #cll #oncology #consensus #medicalaffairs #medicalcommunications #medicalwriting
-
-
Congratulations to the authors and the Merz Aesthetics team on their recent successful publication: Addressing the Real-World Challenges of Immunoresistance to Botulinum Neurotoxin A (BoNT-A) in Aesthetic Practice: Insights and Recommendations from a Panel Discussion in Hong Kong. The paper discusses strategies to mitigate the risk of immunoresistance to BoNT-A in everyday Aesthetic practice: The panel strongly favoured a thorough initial consultation to establish the patient’s treatment history, explain treatment side effects including immunoresistance, and to discuss treatment goals. Where efficacy and safety are comparable, a formulation with the lowest immunogenicity is also preferred. Tech Observer is grateful to have been a part of this project – and in providing medical writing to help bring further awareness of practical risk management strategies for immunoresistance. #medicalcommunications #publication #merzaesthetics
-